ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO077

Patterns of Readmission and Death after Admission with AKI: A Data-Linkage Study

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

  • Barakat, Zena, Northern Centre for Health Education & Research, Epping, Victoria, Australia
  • Pianta, Timothy J., Northern Centre for Health Education & Research, Epping, Victoria, Australia
Background

Despite episode-level data, and health-service level studies, patient-level incidence of AKI across Australia or its
major jurisdictions has not been characterized to date. Important outcomes including discharge to residential aged care, hospital
readmission, and mortality remain undefined. Data linkage allows clarification of patient-level outcomes across a jurisdiction to permit
system-level policy and planning and potentially refine resource allocation.

Methods

Data linkage analysis of jurisdiction-wide administrative data in Victoria, Australia. The study linked the Victorian Admitted
Episodes Dataset (VAED), Victorian Death Index (VDI), Victorian Integrated Non-admitted Health (VINAH), and Victorian Cancer
Registry (VCR) in July 2016 to June 2017. Index admissions with AKI were defined with follow up to 36 months.

Results

2,817,000 admissions were complicated by AKI in 198,966 (7.1%) episodes of care in Victorian hospitals. 38,033 individual adult patients accounted for the 96,549 AKI episodes identified in adults admitted overnight to acute care. AKI incidence was greatest amongst elderly (age ≥75 years; 57.6%), overseas-born, and comorbid patients, but paradoxically less amongst socioeconomically disadvantaged patients.
Inpatient mortality complicated 1,984 (5.2%) of the index admissions.
Most AKI survivors were readmitted [23,757 (65.9%)] at least once (median 3, range 0 – 33), and a majority [20,244 (85.2%)] experienced recurrent AKI within 12 months.
At 12-months, overall mortality was 27.2%, and 22.9% amongst survivors of the index episode with 28.0% of these deaths within 30 days. At 3 years, overall mortality was 46.2%. Cancer was the leading cause of death followed by cardiovascular disease, sepsis, dementia, and kidney failure.

Conclusion

Despite likely underreporting of AKI in Victoria, AKI was a commonly reported and relapsing condition of predominantly
elderly patients. An index episode of AKI was associated with recurrent admission and recurrent AKI in most patients. Discharge to a
residential aged care facility was common. AKI was associated with high mortality, most commonly attributable to cancer rather
than cardiovascular disease. Education, interventional studies, and policy can better reflect the epidemiology of AKI. Further analysis
should clarify previously unexplored interactions between AKI, cancer, residential aged care, avoidable readmission, and mortality.